Emergent BioSolutions | Należności Handlowe





Należności Handlowe Zmiana Data
Acadia Pharmaceuticals USD 139.44M 19.75M 2025-09
Akebia Therapeutics USD 61.54M 27.17M 2025-03
ALKERMES USD 355.11M 1.22M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 127.31M 8.18M 2025-09
ANI Pharmaceuticals USD 252.62M 26.96M 2025-09
BioMarin Pharmaceutical USD 790.27M 65.59M 2025-09
Coherus Biosciences USD 62.44M 59.9M 2025-03
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Exact Sciences USD 306.05M 47.28M 2025-09
Exelixis USD 286.92M 24.38M 2025-12
Glaxosmithkline GBP 11.16B 3.46B 2025-09
Heron Therapeutics USD 67.04M 6.9M 2024-09
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Lexicon Pharmaceuticals USD 2.62M 1.09M 2024-06
Lonza CHF 1.78B 55M 2025-12
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Myriad Genetics USD 118M 19M 2025-09
Nektar Therapeutics USD 0 2.9M 2024-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pacira USD 115.27M 901K 2025-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 203.07M 6.94M 2025-09
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 395.74M 213.86M 2025-09
United Therapeutics USD 297.7M 81.6M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Xoma USD 14.78M 4.96M 2024-06


Emergent BioSolutions Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.